Hno Praxis Am Neckar

At Hno Praxis Am Neckar in Heidelberg, most of the clinical research focuses on birch pollen-induced allergic rhinitis and allergic rhinoconjunctivitis. These studies are designed to evaluate new and existing treatments that may help reduce symptoms and lessen the need for rescue medication during pollen season.

• Testing whether new birch pollen-based therapies can improve day-to-day symptom control in adolescents and adults
• Assessing treatment effectiveness by comparing allergy symptoms and medication use during peak pollen exposure
• Studying options that may offer better relief for children, adolescents, and adults living with seasonal allergy disease

The research highlights practical care for immune system diseases, with a clear emphasis on improving comfort, function, and symptom management for people affected by seasonal pollen allergies.

A smaller part of the site’s portfolio addresses virus diseases, especially COVID-19. These trials aim to better understand recovery in non-hospitalized patients and to assess whether new treatment approaches can support improvement during infection.

• Evaluating therapies intended to improve the course of SARS-CoV-2 infection and speed recovery
• Exploring ways to support patients with mild to moderate COVID-19 outside the hospital setting
• Focusing on treatment effectiveness and patient recovery in a common viral illness

This area of research shows the site’s interest in practical infection-related care, with studies aimed at improving outcomes in everyday clinical settings.